297 related articles for article (PubMed ID: 31417100)
21. What do drug transporters really do?
Nigam SK
Nat Rev Drug Discov; 2015 Jan; 14(1):29-44. PubMed ID: 25475361
[TBL] [Abstract][Full Text] [Related]
22. Fluorescence-based methods for studying activity and drug-drug interactions of hepatic solute carrier and ATP binding cassette proteins involved in ADME-Tox.
Özvegy-Laczka C; Ungvári O; Bakos É
Biochem Pharmacol; 2023 Mar; 209():115448. PubMed ID: 36758706
[TBL] [Abstract][Full Text] [Related]
23. Antitubercular Agent Delamanid and Metabolites as Substrates and Inhibitors of ABC and Solute Carrier Transporters.
Sasabe H; Shimokawa Y; Shibata M; Hashizume K; Hamasako Y; Ohzone Y; Kashiyama E; Umehara K
Antimicrob Agents Chemother; 2016 Jun; 60(6):3497-508. PubMed ID: 27021329
[TBL] [Abstract][Full Text] [Related]
24. Diurnal expression of ABC and SLC transporters in jejunum is modulated by adrenalectomy.
Vagnerová K; Ergang P; Soták M; Balounová K; Kvapilová P; Vodička M; Pácha J
Comp Biochem Physiol C Toxicol Pharmacol; 2019 Dec; 226():108607. PubMed ID: 31422161
[TBL] [Abstract][Full Text] [Related]
25. Expression and splicing of ABC and SLC transporters in the human blood-brain barrier measured with RNAseq.
Suhy AM; Webb A; Papp AC; Geier EG; Sadee W
Eur J Pharm Sci; 2017 May; 103():47-51. PubMed ID: 28188910
[TBL] [Abstract][Full Text] [Related]
26. Alternative Splicing: Expanding Diversity in Major ABC and SLC Drug Transporters.
Park JE; Ryoo G; Lee W
AAPS J; 2017 Nov; 19(6):1643-1655. PubMed ID: 28971357
[TBL] [Abstract][Full Text] [Related]
27. Alterations in transporter expression in liver, kidney, and duodenum after targeted disruption of the transcription factor HNF1alpha.
Maher JM; Slitt AL; Callaghan TN; Cheng X; Cheung C; Gonzalez FJ; Klaassen CD
Biochem Pharmacol; 2006 Aug; 72(4):512-22. PubMed ID: 16806085
[TBL] [Abstract][Full Text] [Related]
28. Overview: Role of Drug Transporters in Drug Disposition and Its Clinical Significance.
Liu X
Adv Exp Med Biol; 2019; 1141():1-12. PubMed ID: 31571163
[TBL] [Abstract][Full Text] [Related]
29. Drug Transporter Function--Implications in CKD.
Schwenk MH; Pai AB
Adv Chronic Kidney Dis; 2016 Mar; 23(2):76-81. PubMed ID: 26979146
[TBL] [Abstract][Full Text] [Related]
30. The organic anion transporter (OAT) family: a systems biology perspective.
Nigam SK; Bush KT; Martovetsky G; Ahn SY; Liu HC; Richard E; Bhatnagar V; Wu W
Physiol Rev; 2015 Jan; 95(1):83-123. PubMed ID: 25540139
[TBL] [Abstract][Full Text] [Related]
31. Genetic variation in the proximal promoter of ABC and SLC superfamilies: liver and kidney specific expression and promoter activity predict variation.
Hesselson SE; Matsson P; Shima JE; Fukushima H; Yee SW; Kobayashi Y; Gow JM; Ha C; Ma B; Poon A; Johns SJ; Stryke D; Castro RA; Tahara H; Choi JH; Chen L; Picard N; Sjödin E; Roelofs MJ; Ferrin TE; Myers R; Kroetz DL; Kwok PY; Giacomini KM
PLoS One; 2009 Sep; 4(9):e6942. PubMed ID: 19742321
[TBL] [Abstract][Full Text] [Related]
32. Post-translational modifications of transporters.
Czuba LC; Hillgren KM; Swaan PW
Pharmacol Ther; 2018 Dec; 192():88-99. PubMed ID: 29966598
[TBL] [Abstract][Full Text] [Related]
33. Potentiating SLC transporter activity: Emerging drug discovery opportunities.
Rives ML; Javitch JA; Wickenden AD
Biochem Pharmacol; 2017 Jul; 135():1-11. PubMed ID: 28214518
[TBL] [Abstract][Full Text] [Related]
34. The Structure and Mechanism of Drug Transporters.
Roberts AG
Methods Mol Biol; 2021; 2342():193-234. PubMed ID: 34272696
[TBL] [Abstract][Full Text] [Related]
35. The SLC transporter in nutrient and metabolic sensing, regulation, and drug development.
Zhang Y; Zhang Y; Sun K; Meng Z; Chen L
J Mol Cell Biol; 2019 Jan; 11(1):1-13. PubMed ID: 30239845
[TBL] [Abstract][Full Text] [Related]
36. Gestational age-dependent changes in gene expression of metabolic enzymes and transporters in pregnant mice.
Shuster DL; Bammler TK; Beyer RP; Macdonald JW; Tsai JM; Farin FM; Hebert MF; Thummel KE; Mao Q
Drug Metab Dispos; 2013 Feb; 41(2):332-42. PubMed ID: 23175668
[TBL] [Abstract][Full Text] [Related]
37. Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine.
Zollner G; Fickert P; Fuchsbichler A; Silbert D; Wagner M; Arbeiter S; Gonzalez FJ; Marschall HU; Zatloukal K; Denk H; Trauner M
J Hepatol; 2003 Oct; 39(4):480-8. PubMed ID: 12971955
[TBL] [Abstract][Full Text] [Related]
38. Transporter-mediated natural product-drug interactions for the treatment of cardiovascular diseases.
Zha W
J Food Drug Anal; 2018 Apr; 26(2S):S32-S44. PubMed ID: 29703385
[TBL] [Abstract][Full Text] [Related]
39. Mass spectrometry-based abundance atlas of ABC transporters in human liver, gut, kidney, brain and skin.
Al-Majdoub ZM; Achour B; Couto N; Howard M; Elmorsi Y; Scotcher D; Alrubia S; El-Khateeb E; Vasilogianni AM; Alohali N; Neuhoff S; Schmitt L; Rostami-Hodjegan A; Barber J
FEBS Lett; 2020 Dec; 594(23):4134-4150. PubMed ID: 33128234
[TBL] [Abstract][Full Text] [Related]
40. Analysis of ABCG2 and other urate transporters in uric acid homeostasis in chronic kidney disease: potential role of remote sensing and signaling.
Bhatnagar V; Richard EL; Wu W; Nievergelt CM; Lipkowitz MS; Jeff J; Maihofer AX; Nigam SK
Clin Kidney J; 2016 Jun; 9(3):444-53. PubMed ID: 27274832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
